Form 4: Vicarious Surgical CFO William Kelly Sells Shares to Cover Tax Obligations
SEC Form 4
William Kelly, CFO of Vicarious Surgical Inc., sold 7,535 shares of Class A Common Stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- William Kelly, the CFO and Treasurer of Vicarious Surgical Inc., sold 7,535 shares of Class A Common Stock on March 4, 2024.
- The sales were executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on June 2, 2023.
- The shares were sold at a weighted average price of $0.3708, with individual trades ranging from $0.357 to $0.38 per share.
- Following the transaction, Kelly directly owns 519,131 shares of Class A Common Stock.
- A Power of Attorney was executed on January 31, 2024, granting authority to Adam Sachs, Erin Checka, and attorneys from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to handle SEC filings on Kelly's behalf.
Sentiment
Score: 6
Explanation: The document is neutral in sentiment. It simply reports a routine stock sale by an executive to cover tax obligations. There are no indications of positive or negative implications for the company's performance.
Industry Context
Sales of shares by company executives are a normal part of corporate governance, often related to compensation and tax obligations. The sale itself is unlikely to have a significant impact on the company's operations or strategy.
Comparison to Industry Standards
- Executive stock sales are common across the industry for various reasons, including diversification, tax obligations, and personal financial planning.
- Comparable companies such as Intuitive Surgical or Medtronic also see regular Form 4 filings related to executive stock transactions.
- The size of the sale (7,535 shares) is relatively small compared to the total outstanding shares and is unlikely to significantly impact the stock price.
Stakeholder Impact
- The stock sale is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| January 31, 2024 | Date of execution of Power of Attorney. |
| March 4, 2024 | Date of stock sale transaction. |
| March 5, 2024 | Date of signature on the Form 4 filing. |
| June 2, 2023 | Date of grant of restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.